Synthesis and Toxicological Evaluation of N-Nitroso Vildagliptin Amide Impurity in BALB 3T3 Clone Cells.

Nitrosamine impurities in pharmaceuticals have become a significant regulatory concern because of their established carcinogenic and genotoxic potential. N-nitroso vildagliptin amide impurity (NNVI), associated with the antidiabetic drug vildagliptin, raises potential safety concerns, yet its biological toxicity remains inadequately explored. To address this gap in our study, we synthesized and characterized NNVI and evaluated its cytotoxic, oxidative, and genotoxic effects using BALB 3T3 cell lines, within the context of the US FDA's acceptable daily intake (ADI) limit for NNVI. NNVI was synthesized under mild acidic conditions via nitrosation of the vildagliptin amide intermediate and confirmed structurally using NMR, IR, and mass spectrometry. BALB 3T3 cells were treated with NNVI at concentrations ranging from 5 to 125 ppm. Cytotoxicity was assessed with the MTT assay, whereas oxidative stress was measured via levels of superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), nitric oxide synthases (iNOS), reduced glutathione (GSH), and Nrf2. Genotoxicity was determined through the alkaline comet assay. The results showed a dose-dependent decrease in cell viability, with significant cytotoxicity observed at concentrations ≥ 50 ppm. Oxidative stress markers indicated adaptive antioxidant responses at lower concentrations (5-25 ppm), but higher concentrations caused oxidative imbalance, antioxidant depletion, and increased lipid peroxidation. Genotoxic effects were evident at 100 ppm, with increased DNA tail intensity. These findings confirm that NNVI presents a toxicological risk at concentrations above regulatory limits. The study underscores the importance of strict impurity control in pharmaceutical formulations and contributes to the wider effort of ensuring drug safety by limiting nitrosamine exposure to acceptable thresholds.

• Publication year

  2025

• Venue

  Journal of Applied Toxicology

• Publication date

  2025-11-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jat.4983PMID 41229198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific Acceptable Intakes.

  2024cited by this paper
• The Cancer Antioxidant Regulation System in Therapeutic Resistance

  2024cited by this paper
• Forced Degradation Products of Olmesartan Medoxomil and their In Vitro Genotoxicity Assessment by Comet Assay using HEK Cells

  2024cited by this paper
• In vitro toxicity of fine and coarse particulate matter on the skin, ocular and lung microphysiological cell-culture systems.

  2023cited by this paper
• Molecular Basis of the KEAP1-NRF2 Signaling Pathway

  2023cited by this paper
• Development and validation of an analytical method for quantitative determination of three potentially genotoxic impurities in vildagliptin drug material using HPLC -MS.

  2021cited by this paper
• Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities.

  2021cited by this paper
• Is this the end for ranitidine? NDMA presence continues to confound

  2021cited by this paper
• Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest.

  2020cited by this paper
• Superoxide Dismutase (SOD) and Catalase (CAT) Activity Assay Protocols for Caenorhabditis elegans.

  2017cited by this paper
• Evaluating In Vitro DNA Damage Using Comet Assay.

  2017cited by this paper
• Antioxidant Systems are Regulated by Nitric Oxide-Mediated Post-translational Modifications (NO-PTMs)

  2016cited by this paper
• Glutathione synthesis.

  2013cited by this paper
• Comet Assay measurements: a perspective

  2009cited by this paper
• Reaction of Peroxynitrite with Mn-Superoxide Dismutase

  2001cited by this paper
• An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

  1997cited by this paper
• Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.

  1994cited by this paper
• Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation.

  1990cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• No citing papers are available for this paper.